
| ROI Name | ∑ In | % In | log ratio | ∑ Out | % Out |
|---|---|---|---|---|---|
| AL_R | 1,528 | 64.6% | 1.85 | 5,508 | 61.9% |
| AL_L | 775 | 32.8% | 2.11 | 3,356 | 37.7% |
| EB | 30 | 1.3% | -0.82 | 17 | 0.2% |
| CRE_R | 16 | 0.7% | -0.30 | 13 | 0.1% |
| MB_ML_R | 8 | 0.3% | -2.00 | 2 | 0.0% |
| LAL_R | 5 | 0.2% | -inf | 0 | 0.0% |
| CRE_L | 2 | 0.1% | -inf | 0 | 0.0% |
| upstream partner | # | NT | conns ORN_DA4m | % In | CV |
|---|---|---|---|---|---|
| ORN_DA4m (R) | 19 | 5-HT | 35.3 | 33.1% | 0.3 |
| ORN_DA4m (L) | 19 | Unk | 11.1 | 10.4% | 0.6 |
| lLN2P_b (R) | 4 | Unk | 8.4 | 7.9% | 0.6 |
| lLN2F_a (R) | 2 | Unk | 6.1 | 5.7% | 0.2 |
| lLN2F_a (L) | 2 | GABA | 3.7 | 3.5% | 0.1 |
| lLN2T_e (R) | 2 | 5-HT | 3.3 | 3.1% | 0.6 |
| ALIN5 (L) | 1 | GABA | 2.9 | 2.7% | 0.0 |
| lLN2X04 (R) | 2 | Unk | 2.5 | 2.4% | 0.1 |
| lLN2P_b (L) | 4 | Unk | 2.5 | 2.4% | 0.5 |
| DA4m_adPN (R) | 1 | ACh | 2.3 | 2.2% | 0.0 |
| lLN2F_b (L) | 2 | GABA | 2.1 | 2.0% | 0.2 |
| lLN2T_b (L) | 2 | Unk | 2.1 | 1.9% | 0.6 |
| lLN2T_b (R) | 2 | Unk | 1.9 | 1.8% | 0.6 |
| lLN2X02 (R) | 3 | GABA | 1.5 | 1.4% | 0.7 |
| ORN_VA1v (R) | 15 | 5-HT | 1.5 | 1.4% | 1.1 |
| lLN2F_b (R) | 1 | GABA | 1.4 | 1.3% | 0.0 |
| lLN2X04 (L) | 2 | GABA | 1.4 | 1.3% | 0.2 |
| lLN2X05 (L) | 2 | Unk | 1.3 | 1.2% | 0.0 |
| lLN2X12 (L) | 7 | ACh | 1.1 | 1.0% | 0.6 |
| ALIN5 (R) | 1 | GABA | 1 | 0.9% | 0.0 |
| lLN2X05 (R) | 2 | 5-HT | 0.9 | 0.8% | 0.1 |
| lLN1_bc (R) | 8 | Unk | 0.8 | 0.7% | 0.3 |
| lLN2T_e (L) | 2 | Unk | 0.7 | 0.7% | 0.3 |
| DA4m_adPN (L) | 1 | ACh | 0.7 | 0.6% | 0.0 |
| lLN2X11 (L) | 2 | 5-HT | 0.7 | 0.6% | 0.4 |
| lLN2X11 (R) | 2 | 5-HT | 0.7 | 0.6% | 0.4 |
| lLN2X09 (R) | 1 | ACh | 0.6 | 0.6% | 0.0 |
| ORN_VA1d (R) | 8 | ACh | 0.5 | 0.5% | 0.5 |
| ORN_VA1v (L) | 10 | ACh | 0.5 | 0.5% | 0.0 |
| ORN_VA1d (L) | 6 | ACh | 0.5 | 0.4% | 0.5 |
| lLN2X09 (L) | 1 | ACh | 0.4 | 0.4% | 0.0 |
| ORN_DA2 (R) | 7 | ACh | 0.4 | 0.4% | 0.3 |
| lLN2X02 (L) | 3 | GABA | 0.4 | 0.3% | 0.8 |
| lLN2X10 (R) | 2 | ACh | 0.4 | 0.3% | 0.1 |
| ORN_DA1 (R) | 7 | ACh | 0.4 | 0.3% | 0.0 |
| lLN2P_a (R) | 2 | Unk | 0.3 | 0.3% | 0.7 |
| lLN2X03 (R) | 1 | 5-HT | 0.2 | 0.2% | 0.0 |
| lLN2P_a (L) | 1 | Glu | 0.2 | 0.2% | 0.0 |
| ORN_DA1 (L) | 3 | ACh | 0.2 | 0.2% | 0.4 |
| ORN_DA4m (na) | 1 | ACh | 0.2 | 0.2% | 0.0 |
| ORN_DA3 (R) | 3 | Unk | 0.2 | 0.2% | 0.4 |
| lLN2X12 (R) | 4 | Unk | 0.2 | 0.2% | 0.0 |
| lLN1_bc (L) | 4 | Unk | 0.2 | 0.2% | 0.0 |
| ORN_DC3 (R) | 2 | ACh | 0.2 | 0.1% | 0.3 |
| il3LN6 (R) | 1 | Unk | 0.2 | 0.1% | 0.0 |
| CSD (L) | 1 | 5-HT | 0.2 | 0.1% | 0.0 |
| ORN_DA4l (L) | 2 | 5-HT | 0.2 | 0.1% | 0.3 |
| lLN2P_c (L) | 2 | GABA | 0.2 | 0.1% | 0.3 |
| lLN2X10 (L) | 1 | ACh | 0.2 | 0.1% | 0.0 |
| ORN_VA7m (R) | 1 | ACh | 0.1 | 0.1% | 0.0 |
| ORN_VA6 (R) | 1 | ACh | 0.1 | 0.1% | 0.0 |
| lLN2X03 (L) | 2 | 5-HT | 0.1 | 0.1% | 0.0 |
| CB2527 (R) | 1 | Unk | 0.1 | 0.1% | 0.0 |
| v2LN30 (R) | 1 | Unk | 0.1 | 0.1% | 0.0 |
| OA-VUMa5 (M) | 1 | OA | 0.1 | 0.1% | 0.0 |
| lLN2P_c (R) | 2 | GABA | 0.1 | 0.1% | 0.0 |
| ORN_DC3 (L) | 2 | ACh | 0.1 | 0.1% | 0.0 |
| lLN2X07 (R) | 1 | ACh | 0.1 | 0.1% | 0.0 |
| CB3326 (R) | 1 | Glu | 0.1 | 0.1% | 0.0 |
| ORN_DL3 (L) | 1 | 5-HT | 0.1 | 0.1% | 0.0 |
| ORN_D (L) | 2 | ACh | 0.1 | 0.1% | 0.0 |
| CB3679 (R) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| ORN_DA4l (R) | 1 | 5-HT | 0.1 | 0.0% | 0.0 |
| ALIN4 (L) | 1 | GABA | 0.1 | 0.0% | 0.0 |
| v2LN41a (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| v2LN34E (R) | 1 | Unk | 0.1 | 0.0% | 0.0 |
| CB1132 (R) | 1 | GABA | 0.1 | 0.0% | 0.0 |
| ORN_DC1 (R) | 1 | Unk | 0.1 | 0.0% | 0.0 |
| ORN_VA1v (na) | 1 | Unk | 0.1 | 0.0% | 0.0 |
| ORN_DA2 (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| ORN_DL5 (R) | 1 | Unk | 0.1 | 0.0% | 0.0 |
| ORN_VA1d (na) | 1 | Unk | 0.1 | 0.0% | 0.0 |
| CB3202 (R) | 1 | GABA | 0.1 | 0.0% | 0.0 |
| ORN_DC1 (L) | 1 | Unk | 0.1 | 0.0% | 0.0 |
| ORN_DC2 (R) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| CB2845 (R) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| DA4l_adPN (R) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| CSD (R) | 1 | 5-HT | 0.1 | 0.0% | 0.0 |
| downstream partner | # | NT | conns ORN_DA4m | % Out | CV |
|---|---|---|---|---|---|
| DA4m_adPN (R) | 1 | ACh | 47.9 | 22.1% | 0.0 |
| ORN_DA4m (R) | 19 | 5-HT | 35.3 | 16.3% | 0.2 |
| DA4m_adPN (L) | 1 | ACh | 23.2 | 10.7% | 0.0 |
| ORN_DA4m (L) | 20 | 5-HT | 11.9 | 5.5% | 0.4 |
| lLN2P_a (R) | 4 | Unk | 7.8 | 3.6% | 1.2 |
| lLN2P_b (R) | 4 | Unk | 7.2 | 3.3% | 0.6 |
| lLN2F_a (L) | 2 | GABA | 6.9 | 3.2% | 0.2 |
| lLN2X12 (L) | 8 | ACh | 6.1 | 2.8% | 0.7 |
| lLN2P_a (L) | 4 | Unk | 5.4 | 2.5% | 0.8 |
| lLN2T_b (L) | 2 | Unk | 5.2 | 2.4% | 0.8 |
| lLN2X04 (L) | 2 | GABA | 5 | 2.3% | 0.1 |
| lLN2X02 (R) | 3 | GABA | 4.1 | 1.9% | 0.1 |
| M_vPNml53 (R) | 4 | GABA | 4.1 | 1.9% | 0.9 |
| lLN2P_b (L) | 4 | GABA | 3.9 | 1.8% | 0.7 |
| lLN2X05 (L) | 2 | Unk | 3.1 | 1.4% | 0.1 |
| lLN2F_a (R) | 2 | Unk | 3 | 1.4% | 0.2 |
| DA4l_adPN (R) | 1 | ACh | 2.7 | 1.2% | 0.0 |
| lLN2P_c (R) | 4 | GABA | 1.9 | 0.9% | 0.5 |
| lLN2F_b (L) | 2 | GABA | 1.7 | 0.8% | 0.0 |
| lLN2T_b (R) | 2 | Unk | 1.7 | 0.8% | 0.8 |
| lLN2P_c (L) | 3 | GABA | 1.7 | 0.8% | 0.8 |
| lLN2X03 (R) | 3 | 5-HT | 1.5 | 0.7% | 0.3 |
| lLN2X10 (L) | 2 | ACh | 1.4 | 0.6% | 0.3 |
| lLN2X11 (L) | 2 | 5-HT | 1.3 | 0.6% | 0.2 |
| CSD (L) | 1 | 5-HT | 1.2 | 0.6% | 0.0 |
| lLN2X09 (R) | 1 | ACh | 1.2 | 0.5% | 0.0 |
| lLN2X04 (R) | 2 | Unk | 1.1 | 0.5% | 0.1 |
| lLN2X03 (L) | 3 | 5-HT | 0.9 | 0.4% | 0.3 |
| il3LN6 (R) | 1 | Unk | 0.9 | 0.4% | 0.0 |
| CB1141,CB1285 (L) | 3 | GABA | 0.9 | 0.4% | 0.5 |
| CB2527 (R) | 2 | Unk | 0.8 | 0.4% | 0.8 |
| lLN2X12 (R) | 4 | Unk | 0.7 | 0.3% | 0.5 |
| CB1824 (R) | 1 | GABA | 0.6 | 0.3% | 0.0 |
| lLN2T_e (L) | 2 | Unk | 0.6 | 0.3% | 0.7 |
| M_vPNml53 (L) | 3 | GABA | 0.6 | 0.3% | 0.4 |
| DA4l_adPN (L) | 1 | ACh | 0.6 | 0.3% | 0.0 |
| CB1141,CB1285 (R) | 2 | GABA | 0.6 | 0.3% | 0.6 |
| lLN2F_b (R) | 1 | GABA | 0.5 | 0.2% | 0.0 |
| CB1824 (L) | 3 | GABA | 0.5 | 0.2% | 1.0 |
| lLN2T_e (R) | 2 | 5-HT | 0.5 | 0.2% | 0.8 |
| lLN2X05 (R) | 2 | 5-HT | 0.5 | 0.2% | 0.6 |
| M_ilPNm90,M_ilPN8t91 (L) | 1 | ACh | 0.4 | 0.2% | 0.0 |
| ORN_DA4m (na) | 1 | ACh | 0.4 | 0.2% | 0.0 |
| lLN2X09 (L) | 1 | ACh | 0.4 | 0.2% | 0.0 |
| ORN_VA1d (R) | 7 | ACh | 0.4 | 0.2% | 0.3 |
| MZ_lv2PN (L) | 1 | GABA | 0.4 | 0.2% | 0.0 |
| CB2761 (R) | 1 | GABA | 0.4 | 0.2% | 0.0 |
| v2LN36 (R) | 1 | 5-HT | 0.4 | 0.2% | 0.0 |
| lLN1_bc (L) | 6 | Unk | 0.4 | 0.2% | 0.3 |
| M_ilPNm90,M_ilPN8t91 (R) | 1 | ACh | 0.4 | 0.2% | 0.0 |
| lLN2X10 (R) | 2 | ACh | 0.4 | 0.2% | 0.1 |
| lLN2X11 (R) | 2 | 5-HT | 0.3 | 0.1% | 0.0 |
| CB3679 (R) | 1 | ACh | 0.3 | 0.1% | 0.0 |
| ORN_VA1v (R) | 4 | ACh | 0.3 | 0.1% | 0.3 |
| ORN_VA6 (R) | 5 | ACh | 0.3 | 0.1% | 0.0 |
| ORN_VA1d (L) | 5 | ACh | 0.3 | 0.1% | 0.0 |
| il3LN6 (L) | 1 | Unk | 0.2 | 0.1% | 0.0 |
| ORN_VA1v (L) | 3 | ACh | 0.2 | 0.1% | 0.4 |
| DA2_lPN (L) | 1 | ACh | 0.2 | 0.1% | 0.0 |
| CB1676 (R) | 1 | ACh | 0.2 | 0.1% | 0.0 |
| ORN_DA1 (R) | 4 | ACh | 0.2 | 0.1% | 0.0 |
| CSD (R) | 1 | 5-HT | 0.2 | 0.1% | 0.0 |
| CB3326 (R) | 1 | Glu | 0.2 | 0.1% | 0.0 |
| ORN_DA2 (R) | 3 | ACh | 0.2 | 0.1% | 0.0 |
| CB2571 (R) | 1 | Unk | 0.2 | 0.1% | 0.0 |
| lLN2T_c (L) | 1 | 5-HT | 0.2 | 0.1% | 0.0 |
| ORN_DC3 (R) | 3 | ACh | 0.2 | 0.1% | 0.0 |
| DNc01 (R) | 1 | DA | 0.2 | 0.1% | 0.0 |
| ORN_DA4l (L) | 2 | 5-HT | 0.2 | 0.1% | 0.3 |
| lLN1_bc (R) | 2 | Unk | 0.2 | 0.1% | 0.3 |
| ORN_DA3 (R) | 3 | Unk | 0.2 | 0.1% | 0.0 |
| OA-VUMa2 (M) | 1 | OA | 0.1 | 0.0% | 0.0 |
| ALIN4 (R) | 1 | GABA | 0.1 | 0.0% | 0.0 |
| lLN2T_c (R) | 1 | 5-HT | 0.1 | 0.0% | 0.0 |
| lLN2X02 (L) | 2 | GABA | 0.1 | 0.0% | 0.0 |
| ORN_DA3 (L) | 2 | Unk | 0.1 | 0.0% | 0.0 |
| v2LN30 (R) | 1 | Unk | 0.1 | 0.0% | 0.0 |
| ORN_VL1 (R) | 2 | Unk | 0.1 | 0.0% | 0.0 |
| ORN_DA4l (R) | 1 | 5-HT | 0.1 | 0.0% | 0.0 |
| OA-VUMa5 (M) | 2 | OA | 0.1 | 0.0% | 0.0 |
| ORN_DM3 (R) | 2 | Unk | 0.1 | 0.0% | 0.0 |
| ORN_DC3 (L) | 2 | ACh | 0.1 | 0.0% | 0.0 |
| CB2845 (R) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| ORN_DL5 (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| v2LN41a (L) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| CB2845 (L) | 1 | GABA | 0.1 | 0.0% | 0.0 |
| ORN_VA1v (na) | 1 | Unk | 0.1 | 0.0% | 0.0 |
| ORN_DA2 (L) | 1 | Unk | 0.1 | 0.0% | 0.0 |
| ORN_DL5 (R) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| CB1266 (R) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| v2LN3A1_b (R) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| ALIN2 (R) | 1 | Glu | 0.1 | 0.0% | 0.0 |
| CB1686 (L) | 1 | GABA | 0.1 | 0.0% | 0.0 |
| DNc02 (R) | 1 | DA | 0.1 | 0.0% | 0.0 |
| ORN_DC2 (R) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| M_vPNml50 (R) | 1 | GABA | 0.1 | 0.0% | 0.0 |
| CB1013 (L) | 1 | Unk | 0.1 | 0.0% | 0.0 |
| lLN9,lLN17a (R) | 1 | ACh | 0.1 | 0.0% | 0.0 |
| lLN1_a (R) | 1 | 5-HT | 0.1 | 0.0% | 0.0 |
| v2LN34E (R) | 1 | Unk | 0.1 | 0.0% | 0.0 |
| ORN_DL3 (L) | 1 | 5-HT | 0.1 | 0.0% | 0.0 |
| lLN10 (R) | 1 | GABA | 0.1 | 0.0% | 0.0 |